Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Journal of Cancer Epidemiology|September 13, 2012
Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-MedicareRobert I Griffiths, Michelle L Gleeson, Joseph Mikhael, et al.Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dLBrian D Bradbury, Mark D Danese, Michelle Gleeson, et al.BMC Cancer|December 25, 2012
Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-MedicareRobert I Griffiths, Mark D Danese, Michelle L Gleeson, et al.BMC Medical Research Methodology|March 19, 2013
Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing diseaseRobert I Griffiths, Cynthia D O'Malley, Robert J Herbert, et al.Journal of Medical Economics|June 22, 2017
Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United KingdomMark D Danese, Michelle Gleeson, Robert I Griffiths, et al.International Journal of Breast Cancer|April 2, 2014
Impact of undetected comorbidity on treatment and outcomes of breast cancerRobert I Griffiths, Michelle L Gleeson, José M Valderas, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Estimated Life-Years Saved in Women with HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United StatesMark D Danese, Anthony Masaquel, Eduardo Santos, et al.American Journal of Nephrology|November 9, 2007
Abnormal bone and mineral metabolism in kidney transplant patients--a reviewStuart M Sprague, Vasily Belozeroff, Mark D Danese, et al.Cancer|June 1, 2012
Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphomaRobert I Griffiths, Michelle L Gleeson, Joseph Mikhael, et al.BMC Nephrology|June 21, 2022
The rate, cost and outcomes of parathyroidectomy in the united states dialysis population from 2016-2018Mark D Danese, Kathleen M Fox, Jennifer L Duryea, et al.Pageof 6